These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 24472554)
21. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. Zhang X; Groopman JE; Wang JF J Cell Physiol; 2005 Jan; 202(1):205-14. PubMed ID: 15389531 [TBL] [Abstract][Full Text] [Related]
22. Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis. Dong Y; Zheng Q; Wang Z; Lin X; You Y; Wu S; Wang Y; Hu C; Xie X; Chen J; Gao D; Zhao Y; Wu W; Liu Y; Ren Z; Chen R; Cui J J Hematol Oncol; 2019 Nov; 12(1):112. PubMed ID: 31703598 [TBL] [Abstract][Full Text] [Related]
23. Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice. Yoshiji H; Kuriyama S; Noguchi R; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Uemura M; Masaki T; Fukui H Gut; 2005 Dec; 54(12):1768-75. PubMed ID: 16033879 [TBL] [Abstract][Full Text] [Related]
24. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity. Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200 [TBL] [Abstract][Full Text] [Related]
25. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469 [TBL] [Abstract][Full Text] [Related]
26. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Gao N; Nester RA; Sarkar MA Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414 [TBL] [Abstract][Full Text] [Related]
27. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development. Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749 [TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells. Yoshiji H; Kuriyama S; Yoshii J; Yamazaki M; Kikukawa M; Tsujinoue H; Nakatani T; Fukui H Hepatology; 1998 Dec; 28(6):1489-96. PubMed ID: 9828211 [TBL] [Abstract][Full Text] [Related]
29. Matrix Stiffness-Upregulated MicroRNA-17-5p Attenuates the Intervention Effects of Metformin on HCC Invasion and Metastasis by Targeting the PTEN/PI3K/Akt Pathway. Gao X; Qiao X; Xing X; Huang J; Qian J; Wang Y; Zhang Y; Zhang X; Li M; Cui J; Yang Y Front Oncol; 2020; 10():1563. PubMed ID: 32974191 [TBL] [Abstract][Full Text] [Related]
30. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084 [TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma. Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319 [TBL] [Abstract][Full Text] [Related]
32. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Cheng JC; Chou CH; Kuo ML; Hsieh CY Oncogene; 2006 Nov; 25(53):7009-18. PubMed ID: 16732316 [TBL] [Abstract][Full Text] [Related]
34. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway. Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943 [TBL] [Abstract][Full Text] [Related]
35. Expression of integrin beta1 and its roles on adhesion between different cell cycle hepatocellular carcinoma cells (SMMC-7721) and human umbilical vein endothelial cells. Song G; Luo Q; Qin J; Wang B; Cai S Colloids Surf B Biointerfaces; 2004 Apr; 34(4):247-52. PubMed ID: 15261064 [TBL] [Abstract][Full Text] [Related]
36. Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells. Zingg D; Riesterer O; Fabbro D; Glanzmann C; Bodis S; Pruschy M Cancer Res; 2004 Aug; 64(15):5398-406. PubMed ID: 15289348 [TBL] [Abstract][Full Text] [Related]
37. N-acetylglucosaminyltranferase VB expression enhances beta1 integrin- dependent PC12 neurite outgrowth on laminin and collagen. Lee I; Guo HB; Kamar M; Abbott K; Troupe K; Lee JK; Alvarez-Manilla G; Pierce M J Neurochem; 2006 May; 97(4):947-56. PubMed ID: 16606368 [TBL] [Abstract][Full Text] [Related]
38. Role of hypoxia-induced fibronectin-integrin β1 expression in embryonic stem cell proliferation and migration: Involvement of PI3K/Akt and FAK. Lee SH; Lee YJ; Han HJ J Cell Physiol; 2011 Feb; 226(2):484-93. PubMed ID: 20677223 [TBL] [Abstract][Full Text] [Related]
39. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways. Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629 [TBL] [Abstract][Full Text] [Related]
40. IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma. Lee JH; Lee H; Yun SM; Jung KH; Jeong Y; Yan HH; Hong S; Hong SS Cancer Lett; 2013 Feb; 329(1):99-108. PubMed ID: 23142281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]